Biodexa Pharmaceuticals PLC (BDRX)

3.90 -0.10 (-2.50%) USD  |  NASDAQ  |  Dec 20, 16:00
3.93 +0.03 (+0.77%) After-Hours: 20:00
More

Biodexa Pharmaceuticals Enterprise Value: -3.645M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for BDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Adaptimmune Therapeutics PLC 18.53M
NuCana PLC -10.48M
TC BioPharm (Holdings) PLC 4.212M
Verona Pharma PLC 3.226B
Autolus Therapeutics PLC -47.65M

Enterprise Value Related Metrics

Earnings Yield -1.91K%
Normalized Earnings Yield -6948.25